Lexogen GmbH
Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest. Lexogen was founded in 2007 with an investment by the AVV Investment Group. Lexogen is supported by the Austrian Research Promotion Agency FFG, the Austria Wirtschaftsservice AWS, INiTS and the Wirtschaftsagentur Wien. Lexogen is based at the Vienna BioCenter in Vienna, Austria, and has a subsidiary in New Hampshire, USA. 50 of Lexogen employees work in R&D.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Research
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2007
About Us
Lexogen is a biotech company focusing on RNA and complete transcriptome studies using next generation sequencing technologies.
We have been at the forefront of RNA research since 2007, and our technologies and products are being used by thousands of scientists all over the world. “Lexo” in Greek means “word”, and Lexogen stands for the word of genes, which is the transcriptome. We strive to be the pioneers in this fascinating field of RNA science, and together with the fastest-growing technology of the past years, the next generation sequencing (NGS), we are sure that we can make a big contribution to the world.
Vision & Mission
Vision
The RNA Experts
Mission
Empower our customers with innovative top quality RNA analysis solutions & support, in order to improve health and well-being for everyone and our planet.
Inclusivity and Equity
Lexogen strives to cultivate an inclusive and accessible workplace where all people feel comfortable being themselves in a safe and supportive environment (a zero tolerance policy applies to disrespect of others).
We believe diversity of background, personality, ability, experience, and thought makes for a better workplace, better decision-making, and more innovation. We focus on cultivating a sense of belonging and an environment where everyone can thrive.
We believe the more our team represents the world around us, the more innovative and performant we are; and the better we are at reaching our vision, because WE, all the team members, are Lexogen.
LGBTQIΠ+, BAME, Dys-X, B-out, disabled, Millenials and seniors… be welcome to join us and help us building Lexogen!
What is so intriguing about the transcriptome?
Grasshoppers are gentle creatures with brilliant green color and mild temper who mostly enjoy their solitude and live in good harmony with neighbors in the environment. But the other brood, the locust, forms huge swarms, darkens the sky, and greedily devours whatever is on their way, sometimes scaring people and frowning the eyebrows of farmers.
What is fascinating is that these two creatures are actually one species, and they share exactly the same genetic information stored in the form of DNA. Under a certain condition, the grasshoppers turn their color into light brown, their legs become short and spiky, and the wings grow to adapt to cover the long distance of swarm travel, becoming one of the most greedy and aggressive populations on earth.
You don’t need to go far away into the jungle of Africa to see such examples, because even in the human body we can observe similar things, like cancer cells which originate from healthy cells with identical genetic information in DNA. What contributes the most to this Dr. Jekyll and Mr. Hyde process is the RNA, or transcription of genomes, which is called transcriptome.
The transcriptome has long been considered as a key for answering many of the questions in genetics, biology and medicine, extending far beyond central dogma. However its applications have been limited due to technical difficulties, and not much was known about it until recent advancements in the Next Generation Sequencing (NGS) technology. Thanks to NGS, we expect to have a much larger amount of RNA data than what we have accumulated so far in the history of biology.